MiR-200c synergizes with trastuzumab-loaded gold nanoparticles to overcome resistance in ovarian cancer cells
Abstract Background Trastuzumab (TZ) resistance remains a significant challenge in the treatment of human epidermal growth factor receptor 2 (HER2)-positive epithelial ovarian cancer (EOC), necessitating novel therapeutic strategies to improve treatment efficacy. Functionalized gold nanoparticles (A...
Saved in:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-06-01
|
| Series: | Cancer Nanotechnology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12645-025-00330-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849767039094226944 |
|---|---|
| author | Tommaso A. Salamone Sofia Marotta Stella Mrmić Salvatore Raffa Sara Cerra Beatrice Pennacchi Martina Mercurio Vincenzo Visco Maurizio Alimandi Maria Rosaria Ricciardi Maurizio Taurino Ilaria Fratoddi Pankaj Trivedi Eleni Anastasiadou |
| author_facet | Tommaso A. Salamone Sofia Marotta Stella Mrmić Salvatore Raffa Sara Cerra Beatrice Pennacchi Martina Mercurio Vincenzo Visco Maurizio Alimandi Maria Rosaria Ricciardi Maurizio Taurino Ilaria Fratoddi Pankaj Trivedi Eleni Anastasiadou |
| author_sort | Tommaso A. Salamone |
| collection | DOAJ |
| description | Abstract Background Trastuzumab (TZ) resistance remains a significant challenge in the treatment of human epidermal growth factor receptor 2 (HER2)-positive epithelial ovarian cancer (EOC), necessitating novel therapeutic strategies to improve treatment efficacy. Functionalized gold nanoparticles (AuNPs) constitute a promising platform for drug delivery and the ability to enhance tumor targeting via the enhanced permeability and retention (EPR) effect. miR-200c, a well-established tumor suppressor microRNA (miRNA), plays a crucial role in inhibiting epithelial-mesenchymal transition (EMT). However, its role in modulating HER2 signaling pathways and sensitizing ovarian cancer cells to TZ remains largely unexplored. Here, we investigate for the first time the combinatorial effect of miR-200c and thiol-functionalized AuNPs (< 10 nm) loaded with TZ (AuNPs-TZ) in overcoming TZ resistance and enhancing treatment efficacy in ovarian cancer cells. Results Pristine AuNPs were not cytotoxic, confirming their biocompatibility as a nanocarrier for TZ delivery. AuNPs were loaded noncovalently with TZ and maintained colloidal stability to prevent aggregation while facilitating effective cellular uptake. Treatment of ovarian cancer cells overexpressing miR-200c with AuNPs-TZ significantly reduced cell viability and increased apoptosis. Immunoblot analysis showed a reduction of phosphorylated HER2 and downstream Kirsten Rat Sarcoma Virus (KRAS) signaling. Furthermore, transmission electron microscopy (TEM) demonstrated morphological changes in miR-200c-transfected ovarian cancer cells and confirmed the localization of AuNPs carrying TZs on the cell membrane and in the cytoplasm. Conclusions These findings highlight the potential of AuNPs-TZ delivery combined with miR-200c as a promising therapeutic strategy to improve the response of HER2-positive EOC to TZ treatment. These results imply the need to further develop AuNP/miRNA-based combinatorial therapies as a viable nanomedicine approach for drug-resistant cancers. Graphical Abstract |
| format | Article |
| id | doaj-art-007db6c8469547b69e721ee37cfef693 |
| institution | DOAJ |
| issn | 1868-6958 1868-6966 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | BMC |
| record_format | Article |
| series | Cancer Nanotechnology |
| spelling | doaj-art-007db6c8469547b69e721ee37cfef6932025-08-20T03:04:22ZengBMCCancer Nanotechnology1868-69581868-69662025-06-0116111910.1186/s12645-025-00330-5MiR-200c synergizes with trastuzumab-loaded gold nanoparticles to overcome resistance in ovarian cancer cellsTommaso A. Salamone0Sofia Marotta1Stella Mrmić2Salvatore Raffa3Sara Cerra4Beatrice Pennacchi5Martina Mercurio6Vincenzo Visco7Maurizio Alimandi8Maria Rosaria Ricciardi9Maurizio Taurino10Ilaria Fratoddi11Pankaj Trivedi12Eleni Anastasiadou13Department of Clinical and Molecular Medicine, Sapienza University of RomeDepartment of Clinical and Molecular Medicine, Sapienza University of RomeDepartment of Clinical and Molecular Medicine, Sapienza University of RomeDepartment of Clinical and Molecular Medicine, Sapienza University of RomeDepartment of Chemistry, Sapienza University of RomeDepartment of Chemistry, Sapienza University of RomeDepartment of Chemistry, Sapienza University of RomeDepartment of Clinical and Molecular Medicine, Sapienza University of RomeDepartment of Clinical and Molecular Medicine, Sapienza University of RomeDepartment of Clinical and Molecular Medicine, Sapienza University of RomeDepartment of Clinical and Molecular Medicine, Sapienza University of RomeDepartment of Chemistry, Sapienza University of RomeDepartment of Experimental Medicine, Sapienza University of RomeDepartment of Clinical and Molecular Medicine, Sapienza University of RomeAbstract Background Trastuzumab (TZ) resistance remains a significant challenge in the treatment of human epidermal growth factor receptor 2 (HER2)-positive epithelial ovarian cancer (EOC), necessitating novel therapeutic strategies to improve treatment efficacy. Functionalized gold nanoparticles (AuNPs) constitute a promising platform for drug delivery and the ability to enhance tumor targeting via the enhanced permeability and retention (EPR) effect. miR-200c, a well-established tumor suppressor microRNA (miRNA), plays a crucial role in inhibiting epithelial-mesenchymal transition (EMT). However, its role in modulating HER2 signaling pathways and sensitizing ovarian cancer cells to TZ remains largely unexplored. Here, we investigate for the first time the combinatorial effect of miR-200c and thiol-functionalized AuNPs (< 10 nm) loaded with TZ (AuNPs-TZ) in overcoming TZ resistance and enhancing treatment efficacy in ovarian cancer cells. Results Pristine AuNPs were not cytotoxic, confirming their biocompatibility as a nanocarrier for TZ delivery. AuNPs were loaded noncovalently with TZ and maintained colloidal stability to prevent aggregation while facilitating effective cellular uptake. Treatment of ovarian cancer cells overexpressing miR-200c with AuNPs-TZ significantly reduced cell viability and increased apoptosis. Immunoblot analysis showed a reduction of phosphorylated HER2 and downstream Kirsten Rat Sarcoma Virus (KRAS) signaling. Furthermore, transmission electron microscopy (TEM) demonstrated morphological changes in miR-200c-transfected ovarian cancer cells and confirmed the localization of AuNPs carrying TZs on the cell membrane and in the cytoplasm. Conclusions These findings highlight the potential of AuNPs-TZ delivery combined with miR-200c as a promising therapeutic strategy to improve the response of HER2-positive EOC to TZ treatment. These results imply the need to further develop AuNP/miRNA-based combinatorial therapies as a viable nanomedicine approach for drug-resistant cancers. Graphical Abstracthttps://doi.org/10.1186/s12645-025-00330-5TrastuzumabHER2AuNPsMicroRNAOvarian cancerDrug delivery |
| spellingShingle | Tommaso A. Salamone Sofia Marotta Stella Mrmić Salvatore Raffa Sara Cerra Beatrice Pennacchi Martina Mercurio Vincenzo Visco Maurizio Alimandi Maria Rosaria Ricciardi Maurizio Taurino Ilaria Fratoddi Pankaj Trivedi Eleni Anastasiadou MiR-200c synergizes with trastuzumab-loaded gold nanoparticles to overcome resistance in ovarian cancer cells Cancer Nanotechnology Trastuzumab HER2 AuNPs MicroRNA Ovarian cancer Drug delivery |
| title | MiR-200c synergizes with trastuzumab-loaded gold nanoparticles to overcome resistance in ovarian cancer cells |
| title_full | MiR-200c synergizes with trastuzumab-loaded gold nanoparticles to overcome resistance in ovarian cancer cells |
| title_fullStr | MiR-200c synergizes with trastuzumab-loaded gold nanoparticles to overcome resistance in ovarian cancer cells |
| title_full_unstemmed | MiR-200c synergizes with trastuzumab-loaded gold nanoparticles to overcome resistance in ovarian cancer cells |
| title_short | MiR-200c synergizes with trastuzumab-loaded gold nanoparticles to overcome resistance in ovarian cancer cells |
| title_sort | mir 200c synergizes with trastuzumab loaded gold nanoparticles to overcome resistance in ovarian cancer cells |
| topic | Trastuzumab HER2 AuNPs MicroRNA Ovarian cancer Drug delivery |
| url | https://doi.org/10.1186/s12645-025-00330-5 |
| work_keys_str_mv | AT tommasoasalamone mir200csynergizeswithtrastuzumabloadedgoldnanoparticlestoovercomeresistanceinovariancancercells AT sofiamarotta mir200csynergizeswithtrastuzumabloadedgoldnanoparticlestoovercomeresistanceinovariancancercells AT stellamrmic mir200csynergizeswithtrastuzumabloadedgoldnanoparticlestoovercomeresistanceinovariancancercells AT salvatoreraffa mir200csynergizeswithtrastuzumabloadedgoldnanoparticlestoovercomeresistanceinovariancancercells AT saracerra mir200csynergizeswithtrastuzumabloadedgoldnanoparticlestoovercomeresistanceinovariancancercells AT beatricepennacchi mir200csynergizeswithtrastuzumabloadedgoldnanoparticlestoovercomeresistanceinovariancancercells AT martinamercurio mir200csynergizeswithtrastuzumabloadedgoldnanoparticlestoovercomeresistanceinovariancancercells AT vincenzovisco mir200csynergizeswithtrastuzumabloadedgoldnanoparticlestoovercomeresistanceinovariancancercells AT maurizioalimandi mir200csynergizeswithtrastuzumabloadedgoldnanoparticlestoovercomeresistanceinovariancancercells AT mariarosariaricciardi mir200csynergizeswithtrastuzumabloadedgoldnanoparticlestoovercomeresistanceinovariancancercells AT mauriziotaurino mir200csynergizeswithtrastuzumabloadedgoldnanoparticlestoovercomeresistanceinovariancancercells AT ilariafratoddi mir200csynergizeswithtrastuzumabloadedgoldnanoparticlestoovercomeresistanceinovariancancercells AT pankajtrivedi mir200csynergizeswithtrastuzumabloadedgoldnanoparticlestoovercomeresistanceinovariancancercells AT elenianastasiadou mir200csynergizeswithtrastuzumabloadedgoldnanoparticlestoovercomeresistanceinovariancancercells |